Artwork

Content provided by Michael Pietrack. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Michael Pietrack or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Player FM - Aplicație Podcast
Treceți offline cu aplicația Player FM !

Episode 2: The Key to Effective Leadership Rob Abbott

30:38
 
Distribuie
 

Manage episode 462122514 series 3552382
Content provided by Michael Pietrack. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Michael Pietrack or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.

Welcome back to the Pharmaverse Podcast!
In episode 2 of Season 2, our host Michael Pietrack interviews Rob Abbott, CEO of ISPOR, discussing the significance of Health Economics and Outcomes Research (HEOR) in the pharmaceutical industry. There is a LOT to learn here, so buckle up for a great episode!
They explore ISPOR's role in influencing health policy, the implications of the Inflation Reduction Act, and the balance between drug affordability and innovation. Abbott emphasizes the importance of evidence-based decision-making in healthcare and the evolving landscape of reimbursement strategies, including the impact of AI. The conversation also touches on ISPOR's future vision and leadership insights for driving change within organizations. What makes a truly effective leader? Rob shares that trust and authenticity are the non negotiable elements of a true leader. Tune in to this phenomenal episode, and be sure to share your comments below!
Takeaways:
🤵ISPOR is the leading professional society for HEOR.
💲HEOR provides critical evidence for market access and pricing.
🔬Government agencies need accessible scientific evidence for policy decisions.
📈The Inflation Reduction Act marks a significant shift in drug pricing.
Balancing affordability and innovation is crucial for the pharmaceutical industry.
💳Outcomes-based contracts are gaining traction in reimbursement strategies.
🩺AI can enhance data analysis and patient outcomes in healthcare.
👨‍⚕️ISPOR aims to transform healthcare accessibility and effectiveness.
▶The pharmaceutical industry will see new players and continued innovation.
🤝Trust and authenticity are key to effective leadership.
Chapters:
00:00
Introduction to ISPOR and HEOR
07:31
Impact of the Inflation Reduction Act
13:12
Innovative Reimbursement Strategies
20:50
The Future of Pharma
25:52
Leadership Insights for Change

  continue reading

19 episoade

Artwork
iconDistribuie
 
Manage episode 462122514 series 3552382
Content provided by Michael Pietrack. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Michael Pietrack or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.

Welcome back to the Pharmaverse Podcast!
In episode 2 of Season 2, our host Michael Pietrack interviews Rob Abbott, CEO of ISPOR, discussing the significance of Health Economics and Outcomes Research (HEOR) in the pharmaceutical industry. There is a LOT to learn here, so buckle up for a great episode!
They explore ISPOR's role in influencing health policy, the implications of the Inflation Reduction Act, and the balance between drug affordability and innovation. Abbott emphasizes the importance of evidence-based decision-making in healthcare and the evolving landscape of reimbursement strategies, including the impact of AI. The conversation also touches on ISPOR's future vision and leadership insights for driving change within organizations. What makes a truly effective leader? Rob shares that trust and authenticity are the non negotiable elements of a true leader. Tune in to this phenomenal episode, and be sure to share your comments below!
Takeaways:
🤵ISPOR is the leading professional society for HEOR.
💲HEOR provides critical evidence for market access and pricing.
🔬Government agencies need accessible scientific evidence for policy decisions.
📈The Inflation Reduction Act marks a significant shift in drug pricing.
Balancing affordability and innovation is crucial for the pharmaceutical industry.
💳Outcomes-based contracts are gaining traction in reimbursement strategies.
🩺AI can enhance data analysis and patient outcomes in healthcare.
👨‍⚕️ISPOR aims to transform healthcare accessibility and effectiveness.
▶The pharmaceutical industry will see new players and continued innovation.
🤝Trust and authenticity are key to effective leadership.
Chapters:
00:00
Introduction to ISPOR and HEOR
07:31
Impact of the Inflation Reduction Act
13:12
Innovative Reimbursement Strategies
20:50
The Future of Pharma
25:52
Leadership Insights for Change

  continue reading

19 episoade

Toate episoadele

×
 
Loading …

Bun venit la Player FM!

Player FM scanează web-ul pentru podcast-uri de înaltă calitate pentru a vă putea bucura acum. Este cea mai bună aplicație pentru podcast și funcționează pe Android, iPhone și pe web. Înscrieți-vă pentru a sincroniza abonamentele pe toate dispozitivele.

 

Ghid rapid de referință

Listen to this show while you explore
Play